The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Study among transgender women and men who have sex with men finds those who opt for online supervised HIV-self testing are more likely to test positive but less likely to seek treatment than those testing offline.
The first ‘real world’ programme to provide PrEP through maternal and child health clinics in a high prevalence setting finds one in five women offered PrEP will take it up.
Viral load testing trial finds 49% are virally unsuppressed while one in five are failing their treatment with suspected drug resistance.
Research on PrEP safety for pregnant women and their babies finds no adverse effects – but knowledge gaps remain.
We have launched a new mobile app made in collaboration with community health workers in Southern Africa. Find out all you need to know about Boost!
Mobile testing and door-to-door approaches result in a 25% increase in status awareness, with particularly significant gains in diagnosing HIV-positive young people and men.
Study with transgender women suggests taking on-demand PrEP with hormone therapy may result in drug levels too low for HIV prevention.
An evaluation of Zvandiri, a teen-led programme for HIV-positive adolescents in Zimbabwe, finds it significantly improves treatment outcomes and boosts self-esteem.
UK efforts to end the HIV epidemic by 2030 are advancing, but challenges remain around reaching those undiagnosed and those diagnosed late.
The largest-ever study examining the effectiveness of condoms for anal sex finds remarkably low levels of failure, and calls to label their use in this way.